Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Seagen Inc.
BeOne Medicines
Bayer
AstraZeneca
Psyence Australia Pty Ltd
Neonc Technologies, Inc.
ViroMissile, Inc.
Jazz Pharmaceuticals
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Genentech, Inc.
BioNTech SE
Brigham and Women's Hospital
Baylor College of Medicine
MacroGenics
Alliance for Clinical Trials in Oncology
Daiichi Sankyo
University of Nebraska
Adela, Inc
Imperial College London
Innate Pharma
Var2 Pharmaceuticals
GlaxoSmithKline
Tanabe Pharma America, Inc.
National Institutes of Health Clinical Center (CC)
Massive Bio, Inc.
Rondo Therapeutics
Washington University School of Medicine
Travera Inc
Nurix Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
858 Therapeutics, Inc.
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Shanghai Public Health Clinical Center
Apollomics Inc.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Monopar Therapeutics
Monopar Therapeutics
Columbia University
Chinese University of Hong Kong
Stanford University
Singlera Genomics Inc.